253 related articles for article (PubMed ID: 26792470)
21. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
[TBL] [Abstract][Full Text] [Related]
22. Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.
Obregón G; Zevallos K; Alarcón V; Puyén ZM; Chávez Inagaki O; Mendoza-Ticona A; Alarcón-Arrascue E; Heldal E; Moore DAJ
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1350-1357. PubMed ID: 30355416
[TBL] [Abstract][Full Text] [Related]
23. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
24. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.
Patel MR; Yotebieng M; Behets F; Vanden Driessche K; Nana M; Van Rie A
Int J Tuberc Lung Dis; 2013 Sep; 17(9):1206-11. PubMed ID: 23827656
[TBL] [Abstract][Full Text] [Related]
26. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
Mpagama SG; Heysell SK; Ndusilo ND; Kumburu HH; Lekule IA; Kisonga RM; Gratz J; Boeree MJ; Houpt ER; Kibiki GS
PLoS One; 2013; 8(5):e62034. PubMed ID: 23675411
[TBL] [Abstract][Full Text] [Related]
28. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
Bonnet M; Bastard M; du Cros P; Khamraev A; Kimenye K; Khurkhumal S; Hayrapetyan A; Themba D; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
Int J Tuberc Lung Dis; 2016 Feb; 20(2):177-86. PubMed ID: 26792469
[TBL] [Abstract][Full Text] [Related]
29. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
[TBL] [Abstract][Full Text] [Related]
30. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
31. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
32. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
33. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection.
Patel MR; Nana M; Yotebieng M; Tabala M; Behets F; Van Rie A
Int J Tuberc Lung Dis; 2014 Jun; 18(6):694-9. PubMed ID: 24903941
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
35. Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin.
Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1405-10. PubMed ID: 24125442
[TBL] [Abstract][Full Text] [Related]
36. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
[TBL] [Abstract][Full Text] [Related]
38. Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
Muchena G; Shambira G; Masuka N; Juru T; Gombe N; Takundwa L; Bangure D; Tshimanga M
Int J Tuberc Lung Dis; 2017 Nov; 21(11):1167-1172. PubMed ID: 29037298
[TBL] [Abstract][Full Text] [Related]
39. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.
Ballif M; Nhandu V; Wood R; Dusingize JC; Carter EJ; Cortes CP; McGowan CC; Diero L; Graber C; Renner L; Hawerlander D; Kiertiburanakul S; Du QT; Sterling TR; Egger M; Fenner L;
Int J Tuberc Lung Dis; 2014 Nov; 18(11):1327-36. PubMed ID: 25299866
[TBL] [Abstract][Full Text] [Related]
40. Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years.
Baghaei P; Tabarsi P; Moniri A; Marjani M; Farnia P; Jabbehdari S; Velayati AA
J Glob Antimicrob Resist; 2017 Dec; 11():116-119. PubMed ID: 28739225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
